2. Gene
  3. Emd - emerin Gene

Emd - emerin Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Rattus norvegicus

基因 ID: 25437 | 基因类型: protein coding

关于 Emd

功能概要

Predicted to enable actin binding activity and beta-tubulin binding activity. Involved in nuclear membrane reassembly. Located in nuclear envelope and spindle. Is integral component of membrane. Human ortholog(s) of this gene implicated in Emery-Dreifuss muscular dystrophy; X-linked Emery-Dreifuss muscular dystrophy 1; and dilated cardiomyopathy. Orthologous to human EMD (emerin). [provided by Alliance of Genome Resources, Apr 2022]

Emd 基因产物(1)

mRNA Protein Name
NM_012948.2 NP_037080.2 emerin
基因本体论
  • 生物过程
  • 细胞组分
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in nuclear membrane reassembly IEP
IEP: 通过表达模式推断
10569247 RGD
细胞组分 GO 注释 逻辑证据 参考文献 来源
located in nuclear envelope IDA
IDA: 通过直接分析推断
10569247 RGD
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断
蛋白主名 其他名称

emerin

相关产品

Approval
生物活性分子 (8)
目录号 产品名 作用方式
纯度 是否罕见病
HY-14721 Tepotinib 99.94% 是
HY-14261 Vilazodone Hydrochloride 99.94% 否
HY-14771A Imeglimin hydrochloride 99.98% 否
HY-14262 Vilazodone 99.84% 否
HY-70057 Safinamide Inhibitor 99.89% 是
HY-70057A Safinamide mesylate Inhibitor 99.07% 是
HY-14721A Tepotinib hydrochloride / 否
HY-14771 Imeglimin / 否
Clinical Phase
生物活性分子 (17)
目录号 产品名 作用方式
纯度 Phase
HY-16141 Cilengitide 99.80% Phase 3
HY-16143 Cilengitide TFA 99.92% Phase 3
HY-100820 Sarizotan Agonist 98.74% Phase 3
HY-107384A Asimadoline hydrochloride Agonist 99.82% Phase 3
HY-107384 Asimadoline Agonist 99.36% Phase 3
HY-100820A Sarizotan hydrochloride Agonist / Phase 3
HY-100820B Sarizotan dihydrochloride Agonist / Phase 3
HY-106246 Pruvanserin Antagonist 99.27% Phase 2
HY-103115 Pruvanserin hydrochloride Antagonist / Phase 2
HY-106100 Roxindole / Phase 2
HY-19273 Rimeporide Inhibitor 98.71% Phase 1
HY-15000 EMD534085 Inhibitor 99.55% Phase 1
HY-103410 Carmoxirole hydrochloride Agonist 99.82% Phase 1
HY-106844 EMD 53998 Inhibitor 99.59% Phase 1
HY-105112 Carmoxirole Agonist / Phase 1
HY-123356 EMD-503982 Inhibitor / Phase 1
HY-19273A Rimeporide hydrochloride Inhibitor / Phase 1
抗体抑制剂 (3)
目录号 产品名 作用方式
纯度 Phase
HY-P991214 Tucotuzumab celmoleukin Activator / Phase 3
HY-P9969 Matuzumab ≥99.0% Phase 2
HY-P99183 Abituzumab Inhibitor 99.38% Phase 2
Pre-clinical Phase
生物活性分子 (35)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-15193 EMD638683 Inhibitor 99.94% 否
HY-P0322 GRGDSPK Inhibitor 98.12% 否
HY-106844A (+)-EMD 57033 Agonist 99.72% 否
HY-101473 EMD527040 Inhibitor 99.88% 否
HY-106150B Eniporide hydrochloride Inhibitor 99.49% 否
HY-107030 Nitrefazole Inhibitor 99.44% 否
HY-136280 Panamesine 99.43% 否
HY-106100A Roxindole hydrochloride 99.53% 否
HY-170410 EMD-95885 Antagonist 98.74% 否
HY-15193B EMD638683 S-Form Inhibitor 99.95% 否
HY-103130 EMD386088 Agonist 99.06% 否
HY-14203 (R)-Safinamide Inhibitor 99.89% 否
HY-19134 EMD 56551 Agonist / 否
HY-15193A EMD638683 R-Form Inhibitor 99.86% 否
HY-103247 EMD 66684 Antagonist / 否
HY-103247B EMD-66684 potassium salt Antagonist / 否
HY-106150 Eniporide / 否
HY-10777 EMD 495235 Inhibitor / 否
HY-114987 EMD 21657 Modulator / 否
HY-114990 EMD 57439 Inhibitor / 否
HY-14262S1 Vilazodone-d8 hydrochloride / 否
HY-169827 EMD-132338 Antagonist / 否
HY-70057S1 Safinamide-d4-1 Inhibitor / 否
HY-A0300 Cyclopeptide-5 Antagonist / 否
HY-P0322A GRGDSPK TFA Inhibitor / 否
HY-P2075 EMD 55068 Antagonist / 否
HY-RS04345 EMD Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-106472 Tioxaprofen Inhibitor / 否
HY-129714 EMD 52297 Inhibitor / 否
HY-14771S Imeglimin-d3 / 否
HY-164394 EMD 1204831 Inhibitor / 否
HY-70057S4 Safinamide-d5 Inhibitor / 否
HY-RS17358 Emd Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS23812 Emd Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W705589 Rimeporide-15N3 hydrochloride Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Emd NCBI NCBI:2010
Macaca fascicularis Emd NCBI NCBI:102138141
Mus musculus Emd NCBI NCBI:13726
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z